These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6169212)

  • 21. Maternal plasma HbF levels in pregnancy.
    James RF; Szumski R; Gillett PG; Shuster J; Gold P
    Oncodev Biol Med; 1983; 4(4):239-44. PubMed ID: 6188131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rh-immune globulin after amniocentesis for genetic diagnosis.
    Henry G; Wexler P; Robinson A
    Obstet Gynecol; 1976 Nov; 48(5):557-9. PubMed ID: 824587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk and grade of feto-maternal hemotransfusion during early amniocentesis].
    Spiazzi L; De Sabata D; Tommasoli RM; Zardini E
    Minerva Ginecol; 1986 Nov; 38(11):889-94. PubMed ID: 2433644
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of passage of fetal erythrocytes into maternal circulation after invasive obstetric procedures.
    Meleti D; De Oliveira LG; Araujo Júnior E; Caetano AC; Boute T; Nardozza LM; Moron AF
    J Obstet Gynaecol Res; 2013 Sep; 39(9):1374-82. PubMed ID: 23822541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit.
    Porra V; Bernaud J; Gueret P; Bricca P; Rigal D; Follea G; Blanchard D
    Transfusion; 2007 Jul; 47(7):1281-9. PubMed ID: 17581165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetomaternal bleeding following diagnostic amniocentesis.
    Lele AS; Carmody PJ; Hurd ME; O'Leary JA
    Obstet Gynecol; 1982 Jul; 60(1):60-4. PubMed ID: 6178064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis.
    Hankins GD; Rowe J; Quirk JG; Trubey R; Strickland DM
    Obstet Gynecol; 1984 Sep; 64(3):353-8. PubMed ID: 6205335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new needle for low risk amniocentesis in early pregnancy (author's transl)].
    Dame WR; Quackernack K
    Z Geburtshilfe Perinatol; 1977 Apr; 181(2):126-8. PubMed ID: 878539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A flow-cytometric equivalent of the Kleihauer test.
    Nelson M; Zarkos K; Popp H; Gibson J
    Vox Sang; 1998; 75(3):234-41. PubMed ID: 9852413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AFP and HbF determination in maternal blood as a parameter of fetomaternal microtransfusion in interventions of the pregnant uterus].
    Alsheimer B; Dericks-Tan JS; Taubert HD
    Geburtshilfe Frauenheilkd; 1985 Oct; 45(10):727-30. PubMed ID: 2415423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic amniocentesis].
    Violante Díaz M; Carrillo Hinojosa M; García Necoechea MP; Escobedo Aguirre F; Lowenberg Favela E; Ahued Ahued JR
    Ginecol Obstet Mex; 1989 Apr; 57():97-102. PubMed ID: 2487310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunoglobulins and antibody titre in amniotic fluid of Rh-isoimmunized pregnant women (author's transl)].
    Mega M; Ongaro G; Paternoster D; Carretti N; De Laurentiis G
    Quad Sclavo Diagn; 1976 Sep; 12(3):258-77. PubMed ID: 828963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.
    Chen JC; Davis BH; Wood B; Warzynski MJ
    Cytometry; 2002 Dec; 50(6):285-90. PubMed ID: 12497589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental localisation by B-scan ultrasound in transabdominal amniocentesis.
    Hinselmann M; Hindemann P; Kubli F
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):503-6. PubMed ID: 5522844
    [No Abstract]   [Full Text] [Related]  

  • 36. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-risk amniocentesis in the third trimester under ultrasound control.
    Piiroinen O; Erkkola R; Grönroos M
    Eur J Radiol; 1984 Nov; 4(4):309-11. PubMed ID: 6394326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new rapid anti-HbF FITC assay, Trillium QuikQuant, for detection and quantitation of foetomaternal haemorrhage.
    Fong EA; Finlayson J; Robins F; Davies J; Joseph J; Rossi E; Grey DE
    Int J Lab Hematol; 2013 Feb; 35(1):106-10. PubMed ID: 22889294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhesus sensitization after midtrimester genetic amniocentesis.
    Brandenburg H; Jahoda MG; Pijpers L; Wladimiroff JW
    Am J Med Genet; 1989 Feb; 32(2):225-6. PubMed ID: 2494888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the ultrasound aspiration transducer in midtrimester amniocentesis.
    Farahani G; Goldman MA; Davis JG; Kardon NB; Mohandes E; Pek H; Fenton AN
    J Reprod Med; 1984 Apr; 29(4):227-31. PubMed ID: 6201613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.